FDA Drug Application (019192) for TRIPHASIL-21 by WYETH PHARMS

Back to FDA Applications sponsored by WYETH PHARMS

Application Number019192
Product Number001
FormTABLET;ORAL-21
Dosage0.03MG;0.04MG;0.05MG;0.075MG;0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRIPHASIL-21
Active IngredientETHINYL ESTRADIOL; LEVONORGESTREL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVONORGESTREL58


Back to FDA Applications sponsored by WYETH PHARMS